![[current-page:title] logo](/sites/default/files/styles/logo/public/default_images/_no-logo.png?itok=8OH0tuUw){kind=logo}
Corporate information
Official name
Pulmagen Therapeutics Limited
Registration country
Company type
CRTH2 antagonists for the treatment of severe asthma and COPD. Signed a subcontracting agreement with Argenta.Funding rounds
| Investor | Profile | Country | |
|---|---|---|---|
|
TTP Venture Managers Ltd | Early stage venture investor in UK IT and clean technology companies |
| Investor | Profile | Country | |
|---|---|---|---|
|
MVM Life Science Partners LLP | Venture capital firm which invests in technologies and products for the life science and healthcare markets |
Investment activity status
Active investor